Path Active Multicentre Randomised Controlled Trial (Previous Pilot: Path Active; Safety and Tolerability Study)

NARecruitingINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

April 2, 2024

Primary Completion Date

December 31, 2025

Study Completion Date

March 31, 2026

Conditions
Diabetic Foot
Interventions
DEVICE

Path Active

Participant use of Path Active insoles, mobile phone app and clinician's dashboard (where pressure and temperature changes can be reviewed by a clinician). All participants will complete a patient questionnaire relating to use of the device and EuroQol - EQ5D at the beginning and end of the study.

OTHER

Control Group

Control Group will receive care as usual.

Trial Locations (1)

NW3 2QE

RECRUITING

Royal Free Hospital, London

All Listed Sponsors
collaborator

Walk With Path

INDUSTRY

lead

Royal Free Hospital NHS Foundation Trust

OTHER